Latest News and Press Releases

Clinical trial comparing 60-day PNS to standard interventions demonstrates superior pain relief for low back pain with SPRINT PNS.

Curonix Publishes Results for IDE PNS Multi-Center Randomized Clinical Trial Resulting in an FDA Expanded Indication for Treating Chronic Craniofacial Pain

Curonix Expands the Freedom® PNS System Patient Treatment Options with the Launch of its Innovative Wearable Solution

SPR announced the peer-reviewed publication of additional survey data demonstrating the impact of SPR® SPRINT® PNS treatment on chronic shoulder pain.

Curonix LLC proudly introduces NervPulseTherapy, an advanced, evidence-based programming platform designed to optimize peripheral nerve stimulation.

Curonix Foundational Clinical Data Published Within the American Society of Interventional Pain Physicians (ASIPP) Peripheral Nerve Stimulation Guidelines

Curonix Receives the First Full-Body Peripheral Nerve Stimulator (PNS) FDA Clearance, including Craniofacial Pain Indication, for its Freedom® PNS System.

Publication of study provides evidence of the impact of SPRINT PNS in relieving post-operative knee pain after total knee arthroplasty (TKA).

Publication of study provides evidence of the impact of SPRINT PNS in relieving post-operative knee pain after total knee arthroplasty (TKA).

Curonix Partners with Sure Med Compliance to Expand PNS Clinical Evidence